PRiME is hosting the third installment of the Connaught Global Challenge Series introducing our partnership with ETH Zurich. This event will feature investigators from both PRiME and ETH Zurich who are working at the forefront of disease-in-a-dish/on-a-chip models and engineering molecular structure for imaging. Registration for this event is required and additional information along with the full program is provided below.

For those who missed the previous symposia in this series, you can view the PRiME-UCSF and the PRiME-HUJI sessions on our YouTube channel.

NOTE: This event has already taken place. You can watch this seminar series on PRiME’s YouTube channel.

PRiME - ETH Zurich Mini Symposium

Models & Tools for Next-Generation Precision Medicine

Monday, September 27, 2021 - 9:00 am to 12:00 pm

9:00 – 9:15 Shana Kelley - Director, PRiME

Introduction to PRiME and the Connaught Global Challenge Program

Disease-in-a-dish/on-a-chip models

9:15 – 9:35 Cornelia Halin - Professor, Department of Chemistry and Applied Biosciences, ETH Zurich                             

"Blocking leukocyte migration for the treatment of corneal transplant rejection”

9:35 – 9:55 Milica Radisic - Professor, Faculty of Applied Science and Engineering, UofT

“Organ-on-a-chip models of COVID-19”

9:55 – 10:15 Klaus Eyer - Assistant Professor, Department of Chemistry and Applied Biosciences, ETH Zurich

“From Bedside to Bench and back – the value of simple model systems and high-resolution single-cell analysis”

10:15 – 10:35 Group Discussion and Q&A

10:35 – 10:40 Break

Engineering molecular structure for imaging

10:40 – 11:00 Ray Reilly - Professor, Leslie Dan Faculty of Pharmacy, UofT; Director, Centre for Pharmaceutical Oncology

“Molecular Imaging of the Delivery of Trastuzumab to Brain Metastases in Patients with HER2-Positive Breast Cancer Enhanced by MR-Guided Focused Ultrasound”

11:00 – 11:20 Roger Schibli – Associate Professor, Department of Chemistry and Applied Biosciences, ETH Zurich; Head, Center for Radiopharmaceutical Science (CRS),

“Nuclear theragnostics from bench-to-bedside”

11:20 – 11:40 Gang Zheng - Associate Research Director & Senior Scientist, Princess Margaret Cancer Centre

“Porphysome nanotheranostics: from discovery toward the first-in-human”

11:40 – 12:00 Group Discussion and Q&A